What Walgreen Company's Earnings Mean for Mutual Fund Investors (WAG)

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Fixed income news, reports, video and more.

Municipal bonds news, reports, video and more.

Practice management news, reports, video and more.

Portfolio management news, reports, video and more.

Retirement news, reports, video and more.

Learn from industry thought leaders and expert market participants.

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

What Walgreen Company's Earnings Mean for Mutual Fund Investors (WAG)

Walgreen Company logo
Walgreen Company (WAG) posted its first quarter financial results before Tuesday’s opening bell. Here’s what the results mean for mutual fund investors.

Inside the Results

Earnings

The company reported earnings of $809 million, or 85 cents per share, up from $695 million, or 72 cents per share, a year ago. On an adjusted basis, earnings came in at $773 million, or 81 cents per share – above analysts’ view of 75 cents per share.

Revenue
Revenue for the quarter was $19.6 billion, up from $18.3 billion last year, Analysts expected to see revenue $19.48 billion.

Benefiting from Low Competition

Although Walgreen’s valuation is not overly expensive, it is still not a “cheap” stock at 27 × 2015 earnings estimates. The company benefits from low competition, with CVS Health (CVS) as its main competitor. Fund managers considering a stake in WAG will be more likely to add to positions if the stock pulls back.

Mutual Funds to Watch

Investors seeking exposure to WAG may consider a mutual fund investment. The funds below currently hold the highest stakes in the company.

The Bottom Line

By investing in one of the funds above, investors are able to gain exposure to a diverse group of holdings and industries. Investors interested in WAG may also be interested in CVS Health (CVS)

Shares of WAG are up 30% YTD.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next

Walgreen Company logo

What Walgreen Company's Earnings Mean for Mutual Fund Investors (WAG)

Walgreen Company (WAG) posted its first quarter financial results before Tuesday’s opening bell. Here’s what the results mean for mutual fund investors.

Inside the Results

Earnings

The company reported earnings of $809 million, or 85 cents per share, up from $695 million, or 72 cents per share, a year ago. On an adjusted basis, earnings came in at $773 million, or 81 cents per share – above analysts’ view of 75 cents per share.

Revenue
Revenue for the quarter was $19.6 billion, up from $18.3 billion last year, Analysts expected to see revenue $19.48 billion.

Benefiting from Low Competition

Although Walgreen’s valuation is not overly expensive, it is still not a “cheap” stock at 27 × 2015 earnings estimates. The company benefits from low competition, with CVS Health (CVS) as its main competitor. Fund managers considering a stake in WAG will be more likely to add to positions if the stock pulls back.

Mutual Funds to Watch

Investors seeking exposure to WAG may consider a mutual fund investment. The funds below currently hold the highest stakes in the company.

The Bottom Line

By investing in one of the funds above, investors are able to gain exposure to a diverse group of holdings and industries. Investors interested in WAG may also be interested in CVS Health (CVS)

Shares of WAG are up 30% YTD.


Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.

Why 30 trillion is invested in mutual funds book

Download our free report

Find out why $30 trillon is invested in mutual funds.


Read Next